Dr. Norman J. Lacayo, MD
Claim this profileLucile Packard Children's Hospital Stanford University
Studies Leukemia
Studies Acute Myelogenous Leukemia
7 reported clinical trials
34 drugs studied
Area of expertise
1Leukemia
2nd or greater relapse
failed at least one re-induction attempt after relapse
refractory disease
2Acute Myelogenous Leukemia
t(9;11) positive
inv(16) positive
t(8;21) positive
Affiliated Hospitals
Clinical Trials Norman J. Lacayo, MD is currently running
Talazoparib + Chemotherapy
for Acute Myeloid Leukemia
This trial is testing the safety of using talazoparib with standard chemotherapy in cancer patients. Talazoparib works by stopping cancer cells from repairing themselves, which could make chemotherapy more effective. The study aims to find the safest dose combination and see if this approach helps patients. Talazoparib is FDA approved for certain types of breast cancer that have spread and were previously treated with chemotherapy.
Recruiting1 award Phase 119 criteria
Niclosamide
for Pediatric Acute Myeloid Leukemia
This trial is testing a combination of two drugs, niclosamide and cytarabine, to treat children with a type of leukemia that has come back or hasn't responded to other treatments. The goal is to see if niclosamide can help cytarabine work better by making cancer cells easier to destroy. Niclosamide is being tested to see if it can help destroy cancer cells more effectively.
Recruiting1 award Phase 11 criteria
More about Norman J. Lacayo, MD
Clinical Trial Related8 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Norman J. Lacayo, MD has experience with
- Cyclophosphamide
- Asparaginase Erwinia Chrysanthemi (recombinant)-rywn
- Blinatumomab
- Bortezomib
- Calaspargase Pegol
- CAR T-cell / Blinatumomab
Breakdown of trials Norman J. Lacayo, MD has run
Leukemia
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Norman J. Lacayo, MD specialize in?
Norman J. Lacayo, MD focuses on Leukemia and Acute Myelogenous Leukemia. In particular, much of their work with Leukemia has involved 2nd or greater relapse patients, or patients who are failed at least one re-induction attempt after relapse.
Is Norman J. Lacayo, MD currently recruiting for clinical trials?
Yes, Norman J. Lacayo, MD is currently recruiting for 2 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that Norman J. Lacayo, MD has studied deeply?
Yes, Norman J. Lacayo, MD has studied treatments such as Cyclophosphamide, Asparaginase Erwinia chrysanthemi (recombinant)-rywn, Blinatumomab.
What is the best way to schedule an appointment with Norman J. Lacayo, MD?
Apply for one of the trials that Norman J. Lacayo, MD is conducting.
What is the office address of Norman J. Lacayo, MD?
The office of Norman J. Lacayo, MD is located at: Lucile Packard Children's Hospital Stanford University, Palo Alto, California 94305 United States. This is the address for their practice at the Lucile Packard Children's Hospital Stanford University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.